Comparing Individualized vs. Weight Based Protocols to Treat Vaso-Occlusive Episodes in Sickle Cell Disease

Stopped Due to COVID enrollment numbers needed to meet the primary endpoint will not be met.

Conditions

• Sickle Cell Disease

Interventions

• OTHER: Patient-Specific Protocol
• OTHER: Weight-based Protocol
• DRUG: Morphine
• DRUG: Hydromorphone

Sponsor

Duke University

Collaborators

• [object Object]